Skip to main content

At the meeting, Mr. Jaap Blaak, who was Chairman of the Board of Supervisory Directors (BOSD) from 2007- 2015, announced that he would be retiring as member of the BOSD, effective immediately.
 

“Jaap joined Pharming’s BOSD at a challenging time, and on his watch Pharming was not only able to survive, but succeed as the first Dutch biotech company to get a first product from its technology platform approved in both the EU and USA.”

- Sijmen de Vries, Pharming’s CEO
Cookies: This website uses cookies Check the cookies page for more information Accept Decline